AMSTERDAM— Researchers from RTI Health Solutions (RTI-HS), a business unit of RTI International, will discuss challenges and solutions for improving European health care at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 17th Annual European Congress in Amsterdam, Nov. 8-12.
More than 45 RTI-HS researchers will deliver poster and oral presentations that span innovations in research methods, best practices, and multiple therapeutic areas including cardiovascular disorders, cancer, vaccines, alcoholism and dermatology. A list of all 31 RTI-HS posters and presentations at the conference can be found here.
Within the theme "New Challenges for Improving European Health Care," the congress will explore how to develop health systems in which health care delivery is both affordable and provides the highest possible quality.
The congress, sponsored by RTI-HS, also includes two days of educational courses, three of which are taught by RTI-HS staff. Nearly 4,000 researchers, decision makers and health technology assessment officials from more than 50 countries are expected to attend.
RTI-HS Head of European Health Economics Sorrel Wolowacz, Ph.D., will moderate an ISPOR Good Research and Practices Task Force Forum titled, "Health State Utility Values: Measuring, Modeling, and Mapping." The task force is developing the first ISPOR guidelines on utility research, which estimates health state utility values for use in calculating quality-adjusted life years. Health state utility values are used by many health technology assessment agencies worldwide to decide whether new medicines and other health technologies will be adopted in health systems.
ISPOR promotes pharmacoeconomics (health economics) and outcomes research, and connects important information to health care decision makers. ISPOR has more than 16,000 members worldwide in nearly 115 countries. Josephine Mauskopf, Ph.D., vice president of Health Economics for RTI-HS is currently a member of the ISPOR board of directors.